Neomorph – $100M Molecular Glue Financing
Neomorph has raised $100 million to advance its molecular glue platform, reinforcing investor confidence in next-generation targeted protein degradation technologies.What HappenedThe company secured $100M in financing to expand development of its molecular glue therapeutics…
